Fundz

N-Power Medicine announces acquisition of Syapse to enhance its oncology clinical research capabilities.

Jan 12, 2025
Redwood CityBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Product Description

N-Power Medicine has acquired Syapse Holdings Inc. to integrate its network and technology, aiming to create the largest community-based prospective clinical research network for oncology. This acquisition will improve patient access to clinical trials and optimize research workflows.

Company Information

Company

N-Power Medicine

Location

Redwood City, California, United States

About

N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.

Fundz sees it the moment N-Power Medicine ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mark hidden

hidden

Maria hidden

Mark hidden

Martin hidden

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for N-Power Medicine's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

N-Power Medicine shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.